tirzepatide treatment kansas Nurse Practitioner Prescribing Mounjaro (Tirzepatide) in Lenexa, Long-Term Tirzepatide Demonstrates Benefits in
Description
SURMOUNT-1 results at 72 weeks This landmark trial published in the New England Journal of Medicine enrolled 2,539 adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related complication
Do not remove the Pen from your skin until you hear the second loud click
The medication mimics and amplifies what your body already does, just with greater intensity and duration
Your preferences: Your comfort with the medication, how it fits into your lifestyle, and your treatment goals are all important factors
This personalization often compresses the timeline to meaningful weight loss and prevents discouragement during slower weeks
One customer reported losing 22 pounds over 5 months
